Clinical Trial Update: The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating very early use of rosuvastatin to prevent recurrence after ischemic stroke was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Severance Hospital | Conditions: Stroke | Phase 3 | Status: TERMINATED